MoneyInvestor's Business Daily
Medpace Stock Hovers Near Entry, Offers Second Chance After July Spike
Medpace stock is back below a buy point of 628.92. The medical research contractor delivered an earnings beat for its second quarter. The post Medpace Stock Hovers Near Entry, Offers Second Chance After July Spike appeared first on Investor's Business Daily.
Join the argument
House rules βComments load as you scroll.